CD1D-Restricted T cells and Pregnancy Loss
CD1D 限制性 T 细胞与流产
基本信息
- 批准号:7570046
- 负责人:
- 金额:$ 37.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:Antigen-Presenting CellsBindingCD40 AntigensCD40 LigandCell physiologyCellsDataDeciduaDecidual Cell ReactionsDendritic CellsDependenceEndometriumEtiologyFrequenciesGalactosylceramidesGlycosphingolipidsGoalsHistocompatibility Antigens Class IHumanImmuneImmune systemInflammatoryLeukocytesLigandsMHC Class I GenesMaternal-Fetal ExchangeMediatingModelingMusNatural Killer CellsPathway interactionsPeptidesPhenotypePopulationPre-EclampsiaPregnancyPregnancy MaintenancePregnancy OutcomePregnancy lossPreparationProductionRegulationResearch PersonnelRoleSignal TransductionStagingSurfaceT-LymphocyteT-Lymphocyte SubsetsTNF geneTNFRSF5 geneTNFSF5 geneTestingUpper armcytokineinsightmacrophagenovelperforinpregnantprogramssuccesstrophoblast
项目摘要
DESCRIPTION (provided by applicant): Successful pregnancy requires the coordinate regulation of the innate and adaptive arms of the immune system. The decidualized endometrium is populated by maternal leukocytes, primarily uterine natural killer (NK) cells, T cells, macrophages, and dendritic cells. The long-term goal of this proposal is to understand the functional relationships among these decidual leukocyte cell subsets and to understand their contribution to the success and maintenance of pregnancy. Semi-invariant NKT (iNKT) cells comprise a novel T cell subset that accumulates in the decidua. iNKT cells recognize CD1d which was recently demonstrated to be expressed on extravillous trophoblast. Our central hypothesis is that decidual iNKT cells can modulate decidual NK cell function, and that this functional relationship may influence pregnancy outcome. Stimulation of iNKT cells in pregnant mice, through administration of the CD1d ligand a-galactosylceramide (aGalCer), induces pregnancy loss in mice. We propose to test our hypothesis by elucidating the mechanism through which iNKT cell activation mediates pregnancy loss in the mouse. Specifically, we propose a model in which aGalCer-stimulated iNKT cells activate CD40+ antigen-presenting cells (APCs). Activated APCs then stimulate decidual NK cells, which ultimately mediate pregnancy loss in a perforin-dependent manner. To test this model we propose the following Specific Aims: (1) to elucidate the iNKT-derived signals required for iNKT cell-mediated pregnancy loss, (2) to elucidate the function and phenotype of the CD40+ intermediate involved in iNKT cell-mediated pregnancy loss, and (3) to elucidate the role and the identity of the cell(s) mediating perforin-dependent pregnancy loss. Completion of these aims may offer insight into the functional contributions of decidual leukocytes to pathological conditions of pregnancy.
描述(由申请人提供):成功的怀孕需要对免疫系统先天和适应性臂的坐标调节。骨化性子宫内膜由母体白细胞填充,主要是子宫天然杀伤(NK)细胞,T细胞,巨噬细胞和树突状细胞。该提案的长期目标是了解这些决定性白细胞细胞子集之间的功能关系,并了解它们对妊娠成功和维持的贡献。半不变的NKT(INKT)细胞组成了一个新型的T细胞子集,该细胞积累了在DECIDUA中积累。 Inkt细胞识别CD1D最近被证明是在跨滋养细胞上表达的。我们的中心假设是,decidual Inkt细胞可以调节deciDual NK细胞功能,并且这种功能关系可能会影响妊娠结局。通过给予CD1D配体A-半乳糖基酰胺(Agalcer)刺激iNKT细胞在小鼠中诱导妊娠丧失。我们建议通过阐明Inkt细胞激活介导小鼠妊娠丧失的机制来检验假设。具体而言,我们提出了一个模型,其中agalcer刺激的Inkt细胞激活CD40+抗原呈递细胞(APC)。然后,激活的APC刺激了deciantal NK细胞,该细胞最终以穿孔蛋白依赖性方式介导妊娠丧失。要测试该模型,我们提出以下特定目的:(1)阐明Inkt细胞介导的妊娠损失所需的INKT衍生信号,(2)阐明与Inkt细胞介导的妊娠有关的CD40+中间体的功能和表型损失,(3)阐明细胞的作用和身份,介导穿孔蛋白依赖性妊娠丧失。这些目标的完成可能会深入了解判决白细胞对怀孕病理状况的功能贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN E BOYSON其他文献
JONATHAN E BOYSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN E BOYSON', 18)}}的其他基金
Development and function of innate-like gamma delta T cells
先天性γδT细胞的发育和功能
- 批准号:
10624417 - 财政年份:2022
- 资助金额:
$ 37.28万 - 项目类别:
Development and function of innate-like gamma delta T cells
先天性γδT细胞的发育和功能
- 批准号:
10527432 - 财政年份:2022
- 资助金额:
$ 37.28万 - 项目类别:
Defining the SAP-dependent and SAP-independent gamma delta TCR repertoire
定义 SAP 相关和 SAP 独立的 gamma delta TCR 指令集
- 批准号:
10170255 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Defining the SAP-dependent and SAP-independent gamma delta TCR repertoire
定义 SAP 相关和 SAP 独立的 gamma delta TCR 指令集
- 批准号:
10043222 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
VERMONT COBRE (BOYSON) PROJECT 4: GENETIC DETERMINANTS OF NKT CELL FUNCTION
佛蒙特州 COBRE (Boyson) 项目 4:NKT 细胞功能的遗传决定因素
- 批准号:
8360771 - 财政年份:2011
- 资助金额:
$ 37.28万 - 项目类别:
VERMONT COBRE (BOYSON) PROJECT 4: GENETIC DETERMINANTS OF NKT CELL FUNCTION
佛蒙特州 COBRE (Boyson) 项目 4:NKT 细胞功能的遗传决定因素
- 批准号:
8167730 - 财政年份:2010
- 资助金额:
$ 37.28万 - 项目类别:
(BOYSON): MOLECULAR DETERMINANTS OF NKT CELL ACTIVATION BY CD1D AND ITS LIGANDS
(Boyson):CD1D 及其配体激活 NKT 细胞的分子决定因素
- 批准号:
7959816 - 财政年份:2009
- 资助金额:
$ 37.28万 - 项目类别:
VERMONT COBRE: PROJECT 1: INKT CELL ACTIVATION BY CD ID & ITS LIGANDS
佛蒙特州 COBRE:项目 1:通过 CD ID 激活 INKT 细胞
- 批准号:
7720915 - 财政年份:2008
- 资助金额:
$ 37.28万 - 项目类别:
相似国自然基金
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment
Fc 增强的 CD40 激动剂抗体用于肿瘤微环境的免疫调节
- 批准号:
10470292 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Defining a novel role for B cells in imprinting CD8 T cells with potent antitumor activity
定义 B 细胞在印记具有有效抗肿瘤活性的 CD8 T 细胞中的新作用
- 批准号:
10304849 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment
Fc 增强的 CD40 激动剂抗体用于肿瘤微环境的免疫调节
- 批准号:
10249062 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
Defining a novel role for B cells in imprinting CD8 T cells with potent antitumor activity
定义 B 细胞在印记具有有效抗肿瘤活性的 CD8 T 细胞中的新作用
- 批准号:
10066640 - 财政年份:2020
- 资助金额:
$ 37.28万 - 项目类别:
T-cell Co-stimulation in Obesity-induced Inflammation and Atherosclerosis
T 细胞协同刺激治疗肥胖引起的炎症和动脉粥样硬化
- 批准号:
8507992 - 财政年份:2013
- 资助金额:
$ 37.28万 - 项目类别: